These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 32116676)

  • 1. Progress in Genetic Polymorphisms Related to Lipid Disturbances Induced by Atypical Antipsychotic Drugs.
    Li N; Cao T; Wu X; Tang M; Xiang D; Cai H
    Front Pharmacol; 2019; 10():1669. PubMed ID: 32116676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of HTR2C, but not LEP or INSIG2, genes with antipsychotic-induced weight gain in a German sample.
    Opgen-Rhein C; Brandl EJ; Müller DJ; Neuhaus AH; Tiwari AK; Sander T; Dettling M
    Pharmacogenomics; 2010 Jun; 11(6):773-80. PubMed ID: 20504252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms of HTR2C, LEP and LEPR on metabolic syndromes in patients treated with atypical antipsychotic drugs.
    Puangpetch A; Unaharassamee W; Jiratjintana N; Koomdee N; Sukasem C
    J Pharm Pharmacol; 2018 Apr; 70(4):536-542. PubMed ID: 29441581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic side effects of antipsychotic drug treatment--pharmacological mechanisms.
    Reynolds GP; Kirk SL
    Pharmacol Ther; 2010 Jan; 125(1):169-79. PubMed ID: 19931306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of INSIG2, MC4R, and LEP are associated with obesity- and metabolic-related traits in schizophrenic patients.
    Kuo PH; Kao CF; Chen PY; Chen CH; Tsai YS; Lu ML; Huang MC
    J Clin Psychopharmacol; 2011 Dec; 31(6):705-11. PubMed ID: 22020349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis.
    Zhang JP; Lencz T; Zhang RX; Nitta M; Maayan L; John M; Robinson DG; Fleischhacker WW; Kahn RS; Ophoff RA; Kane JM; Malhotra AK; Correll CU
    Schizophr Bull; 2016 Nov; 42(6):1418-1437. PubMed ID: 27217270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical antipsychotic drugs perturb AMPK-dependent regulation of hepatic lipid metabolism.
    Oh KJ; Park J; Lee SY; Hwang I; Kim JB; Park TS; Lee HJ; Koo SH
    Am J Physiol Endocrinol Metab; 2011 Apr; 300(4):E624-32. PubMed ID: 21224484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?
    Le Hellard S; Theisen FM; Haberhausen M; Raeder MB; Fernø J; Gebhardt S; Hinney A; Remschmidt H; Krieg JC; Mehler-Wex C; Nöthen MM; Hebebrand J; Steen VM
    Mol Psychiatry; 2009 Mar; 14(3):308-17. PubMed ID: 18195716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications.
    Lett TA; Wallace TJ; Chowdhury NI; Tiwari AK; Kennedy JL; Müller DJ
    Mol Psychiatry; 2012 Mar; 17(3):242-66. PubMed ID: 21894153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HTR2C polymorphisms, olanzapine-induced weight gain and antipsychotic-induced metabolic syndrome in schizophrenia patients: a meta-analysis.
    Ma X; Maimaitirexiati T; Zhang R; Gui X; Zhang W; Xu G; Hu G
    Int J Psychiatry Clin Pract; 2014 Oct; 18(4):229-42. PubMed ID: 25152019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetic Aspects of Antipsychotic Drug-induced Weight Gain - A Critical Review.
    Reynolds GP
    Clin Psychopharmacol Neurosci; 2012 Aug; 10(2):71-7. PubMed ID: 23431082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of antipsychotic-induced weight gain: update and current perspectives.
    Kao AC; Müller DJ
    Pharmacogenomics; 2013 Dec; 14(16):2067-83. PubMed ID: 24279860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined HTR2C-LEP genotype as a determinant of obesity in patients using antipsychotic medication.
    Gregoor JG; Mulder H; Cohen D; van Megen HJ; Egberts TC; Heerdink ER; van der Weide J
    J Clin Psychopharmacol; 2010 Dec; 30(6):702-5. PubMed ID: 21105285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-naive patients with schizophrenia have metabolic disorders that are not associated with polymorphisms in the LEP (-2548G/A) and 5-HTR2C (-759C/T) genes.
    Chen J; Tan L; Long Z; Wang L; Hu L; Yang D
    Int J Clin Exp Pathol; 2018; 11(12):5969-5980. PubMed ID: 31949685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives.
    Baptista T; Kin NM; Beaulieu S; de Baptista EA
    Pharmacopsychiatry; 2002 Nov; 35(6):205-19. PubMed ID: 12518268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain.
    Brandl EJ; Frydrychowicz C; Tiwari AK; Lett TA; Kitzrow W; Büttner S; Ehrlich S; Meltzer HY; Lieberman JA; Kennedy JL; Müller DJ; Puls I
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):134-41. PubMed ID: 22426215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperprolactinemia in Children and Adolescents with Use of Risperidone: Clinical and Molecular Genetics Aspects.
    dos Santos Júnior A; Henriques TB; de Mello MP; Ferreira Neto AP; Paes LA; Della Torre OH; Sewaybricker LE; Fontana TS; Celeri EH; Guerra Júnior G; Dalgalarrondo P
    J Child Adolesc Psychopharmacol; 2015 Dec; 25(10):738-48. PubMed ID: 26682995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 5-HT2C receptor and antipsychoticinduced weight gain - mechanisms and genetics.
    Reynolds GP; Hill MJ; Kirk SL
    J Psychopharmacol; 2006 Jul; 20(4 Suppl):15-8. PubMed ID: 16785265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of 5-HT(2C) receptor gene variants in antipsychotic-induced weight gain.
    Wallace TJ; Zai CC; Brandl EJ; Müller DJ
    Pharmgenomics Pers Med; 2011; 4():83-93. PubMed ID: 23226055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms of the LEP- and LEPR gene and obesity in patients using antipsychotic medication.
    Gregoor JG; van der Weide J; Mulder H; Cohen D; van Megen HJ; Egberts AC; Heerdink ER
    J Clin Psychopharmacol; 2009 Feb; 29(1):21-5. PubMed ID: 19142102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.